Establishing a Robot-Assisted Liver Surgery Program: Early Experience from University Medical Center Ljubljana
<i>Background and Objectives</i>: Robot-assisted procedures represent a significant advancement in minimally invasive liver resection techniques. Nonetheless, the introduction of a novel surgical technique in a new environment necessitates meticulous planning and a gradual, stepwise approach. This study describes the adoption of a robotic surgical platform for liver resection at a high-volume tertiary care center. <i>Materials and Methods</i>: We retrospectively analyzed data that had been prospectively collected from fifty robot-assisted liver resections. Descriptive statistics, including frequencies, percentages, means/medians, and standard deviations, were employed for description and summary. <i>Results</i>: The median operative duration was 166 min (range: 85-400 min), with an average intraoperative blood loss of 200 mL (range: 50-1000 milliliters). Intraoperative or postoperative blood transfusion was required in 8% of patients. Conversion to open resection was necessary in one patient (2%). The mean duration of hospitalization was 5 days (range: 3-20 days), with a 30-day readmission rate of 6% and no mortality within 90 days. Postoperative complications classified as Clavien-Dindo grade 3 or higher were observed in five patients (10%). The mean tumor size varied according to pathology: 58.5 mm (range: 30-120 mm) in the hepatocellular carcinoma group; 27.4 mm (range: 10-32 mm) in the secondary malignancy group; and 42.6 mm (range: 24-60 mm) in the intrahepatic cholangiocarcinoma group. The median number of lymph nodes harvested during lymphadenectomy (IHHCA/GBCA) was 5.4, ranging from 1 to 11. The R0 resection rate for malignant tumors was 88.2% (of 30/34). <i>Conclusions</i>: This study validates the safe integration of robot-assisted surgery into liver disease treatment, supported by our initial experience. Despite its technical advantages, robotic-assisted liver surgery remains complex and demanding. Structured robotic training within established programs, meticulous patient selection, and a stepwise implementation approach are critical during the early phases to optimize the outcomes.
Authors
- Aleš Tomažič (ORCID: https://orcid.org/0000-0002-1063-8636)
- Jan Grosek (ORCID: https://orcid.org/0000-0001-9832-4596)
- Blaž Trotovšek
- Boštjan Plešnik
- Miha Petrič (ORCID: https://orcid.org/0000-0002-1002-4853)
- Živa Nardin
Institutions
- University of Ljubljana (SI)
- Ljubljana University Medical Centre (SI)
Publication Details
- Journal
- Medicina
- Published
- 2025-12-22
- DOI
- https://doi.org/10.3390/medicina62010018
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00